Key considerations in determining fair market value

Navigating complexities in FMV assessments for life sciences 

In today’s rapidly evolving life sciences landscape, establishing fair market value (FMV) is crucial for manufacturers aiming to ensure compliance and maintain integrity in their partnerships with healthcare professionals (HCPs). Life sciences companies must navigate common challenges including cross-border transactions and data availability in FMV assessments. Following established guidelines and understanding these complex issues is essential for companies to develop robust FMV determination. 

Join Baker Tilly for an informative webinar where our team will explore key factors and nuances that impact FMV calculations. We will also discuss insights into effective frameworks and strategies that life science leaders can implement to navigate these challenges. By leveraging data-driven approaches to developing rates and automate tiering, Life Sciences companies can ensure a comprehensive understanding of HCP qualifications, allowing companies to mitigate risks associated with FMV assessments in the global market. 

Who should attend 

• C-Suite, legal, internal audit, medical affairs, and compliance and monitoring professionals at emerging and established life sciences companies   

Presenters 

• Mark Scallon, Principal 
• Valerie Burkholder, Experienced Manager 

Learning objectives 

• Discuss the current industry standards and guidelines in establishing fair market rates and common challenges manufacturers face 
• Explore key factors and nuances to consider effective frameworks manufacturers must maintain to navigate these challenges and maintain compliance and integrity 
• Identify best practices for implementing data-driven approaches in FMV assessments, including automated tiering